OB Holdings Bhd (OB), a leading fortified food and beverages, and dietary supplements manufacturing services provider in Malaysia, is pleased to announce that its wholly-owned subsidiary, Orient Biotech Sdn. Bhd, has entered into 2 separate Letters of Intent (LOI) with CSPC Pharmaceutical subsidiaries, CSPC Innovation Pharmaceutical Co., Ltd and CSPC Weisheng Pharmaceutical (Shijiazhuang) Co., Ltd.
The LOIs, signed on 2 May 2025, established a collaborative framework for both parties to jointly develop specialised functional raw materials by leveraging their respective technological strengths. The collaboration aims to enhance product competitiveness, foster innovation, and expand applications within the functional food and supplement sectors across regional markets.
Teoh Eng Sia, Managing Director of OB Holdings Bhd said, “The signing of these Letters of Intent marks an exciting step forward for OB Holdings as we deepen our upstream capabilities and explore new opportunities in functional ingredients. We are confident that our collaboration with CSPC, a highly respected leader in pharmaceutical innovation, will pave the way for greater product advancement and value creation for our customers.”
OB, through its subsidiaries, specialises in the manufacturing of fortified food and beverage products and dietary supplements for 3rd party brand owners. The Company also develops, markets, and sells its own range of fortified food and beverage products and dietary supplements under various house brands including Bonlife, GoHerb, Zen Night, Sleepin’ Beaute, EZ:Nitez, Beyoute, Zen Youte, and Zenliv. OB also offers contract packing services for products such as vegetable softgel supplements, milk powder, tea leaves, honey, herb powder, fruit powder, and liquid chlorophyll in retail packaging sizes, alongside the trading of milk powder and related activities.
